In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers.
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the ...
Belgium, Mont-Saint-Guibert, 13 January 2026 – Cellistic, a global leader in allogeneic iPSC-derived cell therapy manufacturing, today announced the launch of three new iPSC-derived GMP cell therapy ...
Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...
While current clinical trials for cardiac regeneration using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) ...
Designation underscores the potential of this chemically induced, off-the-shelf cell therapy to address a high unmet need in ...
Explore scalable strategies for iPSC-derived islet differentiation using GMP-grade activin A and KGF to advance diabetes ...
Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...
Prior to 2006, the scientific consensus was that cell differentiation was a one-way street: once mature, cells could not be returned to their initial embryonic-like state, having lost the potential to ...
In June, the U.S. Department of Agriculture approved the production and sale of chicken meat by two companies—Upside Foods and Good Meat—who will each initially partner with a restaurant (Upside with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results